Eagle Bay Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-428
| Closed | -$79K | – | 299 |
|
|
2024
Q4 | $79K | Sell |
428
-105
| -20% | -$19.4K | 0.05% | 255 |
|
|
2024
Q3 | $105K | Sell |
533
-75
| -12% | -$14.8K | 0.04% | 274 |
|
|
2024
Q2 | $126K | Sell |
608
-39
| -6% | -$8.06K | 0.08% | 180 |
|
|
2024
Q1 | $175K | Sell |
647
-158
| -20% | -$42.8K | 0.11% | 140 |
|
|
2023
Q4 | $190K | Sell |
805
-40
| -5% | -$9.46K | 0.12% | 141 |
|
|
2023
Q3 | $166K | Buy |
845
+179
| +27% | +$35.1K | 0.08% | 165 |
|
|
2023
Q2 | $140K | Sell |
666
-114
| -15% | -$24K | 0.08% | 159 |
|
|
2023
Q1 | $157K | Sell |
780
-55
| -7% | -$11.1K | 0.09% | 154 |
|
|
2022
Q4 | $182K | Buy |
835
+550
| +193% | +$120K | 0.1% | 145 |
|
|
2022
Q3 | $57K | Sell |
285
-348
| -55% | -$69.6K | 0.04% | 310 |
|
|
2022
Q2 | $135K | Buy |
633
+478
| +308% | +$102K | 0.08% | 160 |
|
|
2022
Q1 | $44K | Sell |
155
-158
| -50% | -$44.9K | 0.04% | 149 |
|
|
2021
Q4 | $118K | Buy |
313
+48
| +18% | +$18.1K | 0.08% | 148 |
|
|
2021
Q3 | $108K | Sell |
265
-82
| -24% | -$33.4K | 0.06% | 212 |
|
|
2021
Q2 | $130K | Buy |
+347
| New | +$130K | 0.1% | 123 |
|